In this study, we explored the association between early CRP kinetics and prognosis in HCC patients treated with TACE combined with LEN and ICIs (TACE–LEN–ICIs), in order to offer valuable insights for oncologists in their clinical practice. This evidence concerns the gene CRP and hepatocellular carcinoma.